---
figid: PMC4005604__nihms570863f2
figtitle: Targeting the Mevalonate Cascade as a New Therapeutic Approach in Heart
  Disease, Cancer and Pulmonary Disease
organisms:
- NA
pmcid: PMC4005604
filename: nihms570863f2.jpg
figlink: /pmc/articles/PMC4005604/figure/F2/
number: F2
caption: Statins, bisphosphonates, FTIs and GGTIs are different classes of drugs which
  have various inhibitory effects on the MVA pathway. Statins block the conversion
  of HMG-CoA to MVA by suppressing the HMGCR and thereby inhibits Rac geranylgeranylation
  and Ras farnesylation. Statins also attenuate reactive oxygen species (ROS) derived
  from NADPH oxidase. Bisphosphonates (BPs) inhibit the IPP isomerase and isoprenoid
  biosynthesis downstream by targeting FPP synthase and indirectly interfering with
  protein isoprenylation. FTIs and GGTIs are prenyltransferase inhibitors. The formation
  of a covalent bond between the isoprenoids FPP and GGPP and the GTPases (e.g. Ras,
  Rho and Rac) by prenyl transferases is targeted by FTIs and GGTIs. Other inhibitors
  such as squalene synthase inhibitors (SQSIs) and oxidosqualene cyclase inhibitors
  (OSCIs) target the synthesis of the cholesterol precursor squalene and lanosterol
  synthesis, respectively.
papertitle: Targeting the Mevalonate Cascade as a New Therapeutic Approach in Heart
  Disease, Cancer and Pulmonary Disease.
reftext: Behzad Yeganeh, et al. Pharmacol Ther. ;143(1):87-110.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9396299
figid_alias: PMC4005604__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC4005604__F2
ndex: c8d3cf14-dee6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4005604__nihms570863f2.html
  '@type': Dataset
  description: Statins, bisphosphonates, FTIs and GGTIs are different classes of drugs
    which have various inhibitory effects on the MVA pathway. Statins block the conversion
    of HMG-CoA to MVA by suppressing the HMGCR and thereby inhibits Rac geranylgeranylation
    and Ras farnesylation. Statins also attenuate reactive oxygen species (ROS) derived
    from NADPH oxidase. Bisphosphonates (BPs) inhibit the IPP isomerase and isoprenoid
    biosynthesis downstream by targeting FPP synthase and indirectly interfering with
    protein isoprenylation. FTIs and GGTIs are prenyltransferase inhibitors. The formation
    of a covalent bond between the isoprenoids FPP and GGPP and the GTPases (e.g.
    Ras, Rho and Rac) by prenyl transferases is targeted by FTIs and GGTIs. Other
    inhibitors such as squalene synthase inhibitors (SQSIs) and oxidosqualene cyclase
    inhibitors (OSCIs) target the synthesis of the cholesterol precursor squalene
    and lanosterol synthesis, respectively.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ipp
  - CG9784
  - CG9426
  - CG6805
  - Synj
  - INPP5E
  - 5PtaseI
  - gpp
  - tap
  - mys
  - p53
  - betaTub60D
  - hth
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - Cdc42
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - rab
  - Rab5
  - dap
  - DCTN6-p27
  - CG9588
  - Atg1
  - LanB2
  - anon-70Db
  - Mtor
  - Tor
  - MKP-4
  - p38b
  - rl
  - ras
  - Ras64B
  - Ras85D
  - MSX2
  - IPP
  - TP53
  - TP63
  - TP73
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - CDC42
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - AGFG1
  - RAB10
  - RAB11A
  - RAB11B
  - RAB12
  - RAB13
  - RAB14
  - RAB15
  - RAB17
  - RAB18
  - RAB19
  - RAB1A
  - RAB1B
  - RAB1C
  - RAB20
  - RAB21
  - RAB22A
  - RAB23
  - RAB24
  - RAB25
  - RAB26
  - RAB27A
  - RAB27B
  - RAB28
  - RAB2A
  - RAB2B
  - RAB30
  - RAB31
  - RAB32
  - RAB33A
  - RAB33B
  - RAB34
  - RAB35
  - RAB36
  - RAB37
  - RAB38
  - RAB39A
  - RAB39B
  - RAB3A
  - RAB3B
  - RAB3C
  - RAB3D
  - RAB40A
  - RAB40AL
  - RAB40B
  - RAB40C
  - RAB41
  - RAB42
  - RAB43
  - RAB44
  - RAB4A
  - RAB4B
  - RAB5A
  - RAB5B
  - RAB5C
  - RAB6A
  - RAB6B
  - RAB6C
  - RAB7A
  - RAB7B
  - RAB29
  - RAB8A
  - RAB8B
  - RAB9A
  - RAB9B
  - RABL2A
  - RABL2B
  - RABL3
  - IFT22
  - DECR1
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - AKT2
  - AKT3
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - ULK1
  - MTOR
  - NOS3
  - ENO4
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - VIT
  - KRAS
  - HRAS
  - NRAS
  - Bile acids
  - Cholesterol
  - Mevalonate
  - Squalene
  - Cancer
---
